Cargando…
Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial
OBJECTIVES: We evaluated the hypothesis that cyclooxygenase (COX) inhibitor use might have counteracted a beneficial effect of postmenopausal hormone therapy, and account for the absence of cardioprotection in the Women's Health Initiative hormone trials. Estrogen increases COX expression, and...
Autores principales: | Hsia, Judith, Manson, JoAnn E, Kuller, Lewis, Pettinger, Mary, Choe, John H, Langer, Robert D, Limacher, Marian, Oberman, Albert, Ockene, Judith, O'Sullivan, Mary Jo, Robinson, Jennifer G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1584256/ https://www.ncbi.nlm.nih.gov/pubmed/17016543 http://dx.doi.org/10.1371/journal.pctr.0010026 |
Ejemplares similares
-
Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: Findings from the Women’s Health Initiative
por: Al-Rousan, Tala, et al.
Publicado: (2018) -
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases
por: Prentice, Ross L, et al.
Publicado: (2013) -
Can Biomarkers Identify Women at Increased Stroke Risk? The Women's Health Initiative Hormone Trials
por: Kooperberg, Charles, et al.
Publicado: (2007) -
Resting heart rate as a low tech predictor of coronary events in
women: prospective cohort study
por: Hsia, Judith, et al.
Publicado: (2009) -
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects
por: Zhao, Shanshan, et al.
Publicado: (2014)